Previous 10 | Next 10 |
VANCOUVER, Washington, Jan. 13, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...
HOLLYWOOD, CA / ACCESSWIRE / January 10, 2020 / Breast cancer and HIV treatment, solar, tequila awards, CBD cosmetics, cannabis products, 1,100 episodes; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes...
VANCOUVER, Washington, Jan. 09, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...
CytoDyn Inc. ( OTCQB:CYDY ) recently publicized that they have signed a U.S. commercial agreement with Vyera for PRO 140 in HIV indications. In return, CytoDyn will receive an upfront payment and milestone payments worth up to the royalty on net sales. This was one of the most anticipated ca...
Editor's note: Seeking Alpha is proud to welcome Jannik Reiners as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » Introduction ...
The FDA Breakthrough Therapy Designation (BTD) was an offshoot of the Food and Drug Administration Safety and Innovation Act (FDASIA) that was signed on July 9, 2012 , that called for a new designation to be created. Since 2012, only 147 drugs have been approved having this designation, which...
VANCOUVER, Washington, Dec. 23, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...
These Penny Stocks Are On A Roll Right Now When it comes to finding the best penny stocks to buy , you really have to consider your personal approach to the stock market. Are you a day-trader, do you prefer swing trading, do you scalp trades, or are you a true investor? All of these have defi...
Can These Penny Stocks Score Big After New Updates? One of the things that need to be kept in mind with regards to penny stocks is that these stocks give almost anyone the opportunity to make a fortune in the stock market. Though “fortune” is subjective to the eye of the behold...
CytoDyn ( OTCQB:CYDY ) inks an agreement with privately held Vyera Pharmaceuticals related to HIV med leronlimab. More news on: CytoDyn Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Terms of the settlement include $12,000,000 cash payment to CytoDyn and elimination of $14,000,000 accounts payable liability from the Company’s balance sheet VANCOUVER, Washington, July 09, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a bio...
VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that its preclinical MASH study with SMC ...
VANCOUVER, Washington, May 28, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Dr. Jacob P. Lalezari, Chief Executiv...